Spots Global Cancer Trial Database for dna repair
Every month we try and update this database with for dna repair cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency | NCT02975934 | Metastatic Cast... | Rucaparib Abiraterone ace... | 18 Years - | pharmaand GmbH | |
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas | NCT01051635 | Neoplasms Lymphoma | LMP400 LMP776 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy | NCT00001813 | Cockayne Syndro... Skin Neoplasms Xeroderma Pigme... Trichothiodystr... Genodermatosis | 6 Weeks - | National Institutes of Health Clinical Center (CC) | ||
| Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma | NCT03397394 | Bladder Cancer Urothelial Carc... Metastatic Urot... Renal Pelvis Ca... Ureter Carcinom... Urinary Bladder... Urethra Carcino... Muscle Invasive... | Rucaparib | 18 Years - | pharmaand GmbH | |
| ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer | NCT01445522 | Neoplasms Lymphoma | ABT-888 Cyclophosphamid... | 18 Years - 110 Years | National Institutes of Health Clinical Center (CC) | |
| Molecular Epidemiology of Cutaneous Malignant Melanoma | NCT00341991 | Melanoma | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| SU5416 and Carboplatin to Treat Ovarian Cancer | NCT00006155 | Fallopian Tube ... Ovarian Cancer Peritoneal Neop... | SU5416 and carb... | - | National Institutes of Health Clinical Center (CC) | |
| Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors | NCT03875313 | Solid Tumor Clear Cell Rena... TNBC - Triple-N... Colorectal Canc... CRC RCC ccRCC | CB-839 Talazoparib | 18 Years - | Calithera Biosciences, Inc | |
| A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency | NCT02975934 | Metastatic Cast... | Rucaparib Abiraterone ace... | 18 Years - | pharmaand GmbH | |
| Tabectedin to Treat Children and Adolescents With Cancer | NCT01453283 | Solid Tumors | Trabectedin (ec... | 4 Years - 16 Years | National Institutes of Health Clinical Center (CC) | |
| A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) | NCT03207347 | Mesothelioma Uveal Melanoma Renal Cell Carc... Cholangiocarcin... | Niraparib | 18 Years - 80 Years | University of Florida | |
| A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes | NCT04171700 | Solid Tumor | Rucaparib | 18 Years - | pharmaand GmbH | |
| Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors | NCT03875313 | Solid Tumor Clear Cell Rena... TNBC - Triple-N... Colorectal Canc... CRC RCC ccRCC | CB-839 Talazoparib | 18 Years - | Calithera Biosciences, Inc | |
| SU5416 and Carboplatin to Treat Ovarian Cancer | NCT00006155 | Fallopian Tube ... Ovarian Cancer Peritoneal Neop... | SU5416 and carb... | - | National Institutes of Health Clinical Center (CC) | |
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas | NCT01051635 | Neoplasms Lymphoma | LMP400 LMP776 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan | NCT00249977 | Solid Tumors Cancer | Capecitabine in... | 18 Years - | University of New Mexico | |
| ABT-888 Plus Metronomic Cyclophosphamide to Treat Cancer | NCT01445522 | Neoplasms Lymphoma | ABT-888 Cyclophosphamid... | 18 Years - 110 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
